Literature DB >> 18025784

Cerebral glucose metabolism in dizygotic twin pairs discordant for Alzheimer's disease.

Jyri J Virta1, Mira Karrasch, Jaakko Kaprio, Markku Koskenvuo, Ismo Räihä, Tapio Viljanen, Juha O Rinne.   

Abstract

Positron emission tomography (PET) with 2-deoxy-2[(18)F]-fluoro-D-glucose (FDG) can be used to estimate regional cerebral glucose metabolism (rCMRgluc). FDG-PET studies have shown rCMRgluc to be reduced especially in temporal and parietal cortices in Alzheimer's disease (AD). A previous study on monozygotic twins discordant for AD showed that the rCMRgluc of the non-demented twins is reduced significantly in the lateral temporal and parietal cortices compared to unrelated controls. In this study we examined 9 pairs of dizygotic twins discordant for AD with FDG-PET. The rCMRgluc of the demented twins was 16% lower in the prefrontal cortex (p = 0.04), 20% lower in the hippocampus (p = 0.002) and 15% lower in the lateral temporal cortex (p = 0.003) compared to controls. The non-demented twins showed no such reductions on any cortical region compared to unrelated control subjects. This implies that both genes and environment, and not genes alone, are causative in the pathogenesis of AD. (c) 2007 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18025784     DOI: 10.1159/000111114

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  2 in total

Review 1.  Brain glucose hypometabolism and oxidative stress in preclinical Alzheimer's disease.

Authors:  Lisa Mosconi; Alberto Pupi; Mony J De Leon
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

2.  Peripheral blood DNA methylation differences in twin pairs discordant for Alzheimer's disease.

Authors:  Mikko Konki; Maia Malonzo; Ida K Karlsson; Noora Lindgren; Bishwa Ghimire; Johannes Smolander; Noora M Scheinin; Miina Ollikainen; Asta Laiho; Laura L Elo; Tapio Lönnberg; Matias Röyttä; Nancy L Pedersen; Jaakko Kaprio; Harri Lähdesmäki; Juha O Rinne; Riikka J Lund
Journal:  Clin Epigenetics       Date:  2019-09-02       Impact factor: 6.551

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.